NVAX
Novavax, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website novavax.com
- Employees(FY) 1992
- ISIN US6700024010
Performance
-10.36%
1W
-16.5%
1M
+177.04%
3M
+149.5%
6M
+161.46%
YTD
+70.05%
1Y
Profile
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Investment Analysis Report: NVAX
Overview
In this investment analysis report, we will delve into a detailed examination of NVAX, a biotechnology company operating in the Health Technology sector. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, capital expenditure ...
Technical Analysis of NVAX 2024-05-31
Overview:
In analyzing the technical indicators for NVAX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-09 23:25
- 2024-05-09 22:53
- 2024-05-09 22:36
- 2024-05-09 22:34
- 2024-05-09 22:20
- 2024-05-09 22:06
- 2024-05-09 22:06
- 2024-05-09 22:05
Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal(Yahoo Finance)
- 2024-05-09 21:54
- 2024-05-09 21:53
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi(Yahoo Finance)
- 2024-05-09 21:17
Stock markets, China tariffs, Novavax and Sanofi: 3 Things(Yahoo Finance)
- 2024-05-09 20:53
Sector Update: Health Care(Yahoo Finance)
- 2024-05-09 20:27
Novavax Stock Surges 120% on $1.4 Billion Deal With Sanofi(Yahoo Finance)
- 2024-05-09 19:58
Why Is Novavax (NVAX) Stock Up 118% Today?(Investorplace)
- 2024-05-09 19:30
- 2024-05-09 19:05
- 2024-05-09 17:03
Novavax: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-09 14:35
- 2024-05-09 14:15
- 2024-05-09 14:00
- 2024-05-09 14:00
- 2024-05-09 05:06
- 2024-05-07 10:00
- 2024-05-07 09:25
- 2024-05-06 22:00
- 2024-05-06 21:25
- 2024-05-06 15:03
- 2024-05-06 13:45
- 2024-05-06 08:18
- 2024-05-06 06:47